Skip to main content

Media Advisory: Be Sure to Fact Check Joseph Mangano, Janette Sherman and Robert Alvarez

We've gotten a heads up that Joseph Mangano, the brains behind the "Tooth Fairy" project, will be holding a press conference tomorrow afternoon fronting more junk science about nuclear energy. He'll be back with the usual suspects, Robert Alvarez and Janette Sherman, this time claiming that closing the Rancho Seco nuclear plant (click here for a photo) in California "might" have coincided with a decrease in cancer deaths.

Mangano and company are making these claims despite the fact that nuclear power plants only account for .1% of the radiation that a typical American is exposed to over the course of a year. Meanwhile, exposures from life saving medical procedures like CT scans and X-Rays account for about 50%.

Putting that aside, a number of third party experts and journalists have regularly taken turns debunking Mangano's research. In 2011, Michael Moyer of Scientific American said the following about one Mangano study that claimed Americans were suffering from severe health effects in the wake of Fukushima:
[A] check reveals that the authors’ statistical claims are critically flawed—if not deliberate mistruths.

[...]

Only by explicitly excluding data from January and February were Sherman and Mangano able to froth up their specious statistical scaremongering.

This is not to say that the radiation from Fukushima is not dangerous, nor that we shouldn’t closely monitor its potential to spread (we should). But picking only the data that suits your analysis isn’t science—it’s politics. Beware those who would confuse the latter with the former.
Thankfully, it appears that more and more journalists are starting to ask hard questions when it comes to Mangano's soundbites. In December 2011, Barbara Ostrov from Reporting on Health, a blog sponsored by USC Annenberg, warned journalists to "proceed with caution," when it came to Mangano's claims, especially considering that his research can only seem to find a home in a relatively obscure publication. To say the least, NEI echoes Ms. Ostrov's advice, and urges reporters to rigorously question his findings while also seeking out third party experts for their opinions.

Comments

EntrepreNuke said…
Good job of calling out this upcoming report while avoiding an ad hominem.

A key component of science in general and of a healthy nuclear safety culture is to maintain a questioning attitude, and these self-proclaimed researchers should not be immune to being questioned.

Based on the history of these familiar names, I feel confident that I could roughly write out the conclusion they will claim to reach without me ever having need to look at the data they collected.
richardw said…
"I feel confident that I could roughly write out the conclusion they will claim to reach without me ever having need to look at the data they collected."

Which is of course doing exactly what you are accusing them of doing.
Joseph said…
According to Joseph Mangano, there was an increase in infant mortality in Philadelphia right after the Fukushima meltdown. This is a bit strange since the radioiodine levels there were higher before the meltdown.
Engineer-Poet said…
"According to Joseph Mangano, there was an increase in infant mortality in Philadelphia right after the Fukushima meltdown."

This must be the "spooky action at a distance" that the deniers of the Copenhagen interpretation didn't like.

Either that, or the ghetto population had an upsurge in drinking and drug abuse.  I'd put my money there.

Popular posts from this blog

Fluor Invests in NuScale

You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...

Wednesday Update

From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...